QUIDELORTHO CORP Interest Expense Nonoperating
QUIDELORTHO CORP (QDEL) reported Interest Expense Nonoperating of $54.70 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- QUIDELORTHO CORP interest expense nonoperating for the quarter ending 2026-06-28 was $54.70M, a 35.06% increase year-over-year.
- QUIDELORTHO CORP interest expense nonoperating for the quarter ending 2026-03-29 was $51.10M, a 27.75% increase year-over-year.
- QUIDELORTHO CORP interest expense nonoperating for the quarter ending 2025-12-28 was $51.00M, a 25.62% increase year-over-year.
- QUIDELORTHO CORP interest expense nonoperating for the quarter ending 2025-09-28 was $46.10M, a 7.46% increase year-over-year.
- QUIDELORTHO CORP interest expense nonoperating for fiscal 2025 was $177.60M, a 8.62% increase from fiscal 2024.
- QUIDELORTHO CORP interest expense nonoperating for fiscal 2024 was $163.50M, a 10.77% increase from fiscal 2023.
- QUIDELORTHO CORP interest expense nonoperating for fiscal 2023 was $147.60M, a 94.98% increase from fiscal 2023.
- QUIDELORTHO CORP interest expense nonoperating for fiscal 2023 was $75.70M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-28 | $54.70M 10-Q · filed 2026-08-07 | $105.80M 10-Q · filed 2026-08-07 | $156.80M derived: sum of 3 quarters · filed 2026-08-07 | $202.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $51.10M 10-Q · filed 2026-05-06 | $102.10M derived: sum of 2 quarters · filed 2026-05-06 | $148.20M derived: sum of 3 quarters · filed 2026-05-06 | $188.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $97.10M derived: sum of 2 quarters · filed 2026-02-19 | $137.60M derived: sum of 3 quarters · filed 2026-08-07 | $177.60M 10-K · filed 2026-02-19 |
| 2025-09-28 | $46.10M 10-Q · filed 2025-11-06 | $86.60M derived: sum of 2 quarters · filed 2026-08-07 | $126.60M 10-Q · filed 2025-11-06 | $167.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $40.50M 10-Q · filed 2026-08-07 | $80.50M 10-Q · filed 2026-08-07 | $121.10M derived: sum of 3 quarters · filed 2026-08-07 | $164.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $40.00M 10-Q · filed 2026-05-06 | $80.60M derived: sum of 2 quarters · filed 2026-05-06 | $123.50M derived: sum of 3 quarters · filed 2026-05-06 | $164.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $40.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $83.50M derived: sum of 2 quarters · filed 2026-02-19 | $124.50M derived: sum of 3 quarters · filed 2026-02-19 | $163.50M 10-K · filed 2026-02-19 |
| 2024-09-29 | $42.90M 10-Q · filed 2025-11-06 | $83.90M derived: sum of 2 quarters · filed 2025-11-06 | $122.90M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $41.00M 10-Q · filed 2025-08-06 | $80.00M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $39.00M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $147.60M 10-K · filed 2026-02-19 | |||
| 2023-01-01 | $75.70M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |